De Quervain's thyroiditis pathophysiology: Difference between revisions
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{De Quervain's thyroiditis }} | {{De Quervain's thyroiditis }} | ||
{{CMG}} {{MMF}} | {{CMG}}; {{AE}} {{MMF}} | ||
==Overview== | ==Overview== | ||
Revision as of 18:29, 1 August 2017
De Quervain's thyroiditis Microchapters |
Differentiating De Quervain's thyroiditis from other Diseases |
---|
Diagnosis |
Treatment |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Furqan M M. M.B.B.S[2]
Overview
Pathophysiology
Pathogenesis
The exact pathogenesis of de Quervain's thyroiditis is unclear. Cytotoxic T cell recognition of viral and cell antigens presented in a complex leading to thyroid follicular cell damage has been proposed as the pathogenesis of de Quervain's thyroiditis. De Quervain's thyroiditis is usually preceded by a viral prodrome. Various viral infections are associated with the de Quervain's thyroiditis including mumps, adenovirus, Epstein–Barr virus, coxsackievirus, cytomegalovirus, influenza, echovirus, and enterovirus.
Genetics
- De Quervain's thyroiditis is associated with the histocompatibility antigen (HLA) B35.
- In some cases of De Quervain's thyroiditis HLA B15/62 positivity was also reported.
Pathology
The primary pathology of de Quervain's thyroiditis is:
- Destruction of the follicular epithelium
- Loss of the follicular integrity